KALRAY/EASYMILE
6.1.2021 18:02:21 CET | Business Wire | Press release
Autonomous technology provider EasyMile and intelligent processors supplier Kalray have deepened their relationship with the signature of a Memorandum of Understanding (MoU) formalizing their relationship to develop intelligent systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210106005553/en/
The partnership follows their work together in the ten-partner-strong ES3CAP collaborative project, led by Kalray and announced in 2019. The ES3CAP program, with a budget of €22.2 million over 3 years, aims to build a hardware and software platform intended for manufacturers developing critical applications requiring high computing capacity in the fields of aeronautics (aviation, flying cabs, UAVs), defense and, autonomous vehicles.
EasyMile’s technology interacts with all kinds of next-generation radars, cameras, and lidar sensors to autonomize a range of vehicles. Its vehicle-agnostic software makes it the partner of choice for global Original Equipment Manufacturers (OEMs). As a fabless company, EasyMile develops autonomous vehicle solutions that tackle identified use-cases very precisely using common-core, unique technology. EasyMile’s solutions require underlying platforms providing both safety and performance.
Benoit Perrin, Managing Director of EasyMile : “Safety and performance reliability are key to embedded systems. This collaboration with Kalray, which started with the ES3CAP program, matches the high criteria we expect of our partners and we are delighted to be working with them .”
Eric Baissus, CEO of Kalray : ”EasyMile is one of the most advanced companies delivering safe solutions for autonomous vehicles. For us, this collaboration is further evidence of the value that our MPPA® intelligent processors and SuperECU® solution can bring to easily build safe autonomous systems .”
Autonomous vehicles require ECUs (“Electronic Computing Unit”) capable of running a multitude of applications in parallel with no compromise on safety. Kalray’s SuperECU®, based on Kalray MPPA® Intelligent Processor, is a patented platform capable of providing both the demanding performance required to compute functions such as artificial intelligence algorithms but also to support multi-applications with different levels of criticality on the same chip. Kalray’s MPPA® processor is one of the rare solutions on the market to ensure complete freedom from interference between these applications, which is a key attribute in building safe systems.
In addition, Kalray intelligent processors are not only capable of executing AI algorithms but can also simultaneously execute a wide set of different processing such as mathematical algorithms, signal processing and networking software stacks. This heterogenous multi-processing capability is also a critical requirement for autonomous vehicles, and is a unique capability of Coolidge™, 3rd generation of MPPA® processor available now.
ABOUT EASYMILE
EasyMile provides software and complete solutions for driverless mobility and goods transportation. EasyMile partners with manufacturers to autonomize their vehicles with award-winning technology built on safety-by-design, ready for deployment today.
Since 2014, Easymile has become known for quality delivery and real-world deployments. Its proven technology has driven autonomous vehicles in 300+ locations in more than 30 countries: The EZ10 is the most deployed autonomous shuttle in the world. For material handling, TractEasy is a tow-truck solution optimizing supply chains with cross/indoor-outdoor, 24/7 material handling at factories and industrial sites.
With several mass operations around the world EasyMile was the first to deploy fully driverless at Level 4 of autonomous driving. It was also the first autonomous vehicle solutions provider to be ISO 9001 certified. At the core of EasyMile's cutting-edge sofware is a step-by-step approach to safety proven by a zero-collision record. EasyMile's future-ready technology specializes in robotics, computer vision and vehicle dynamics powered by deep learning. Among its customers leading transport operators, city authorities, airports, business parks, manufatcurers, factories, logistics centers and universities.
Headquartered in Toulouse, France, the company employs close to 250 highly qualified employees. In addition to the two founders, Gilbert Gagnaire and Philippe Ligier, EasyMile has investors who are also technical partners: Alstom, Continental and Bpifrance. www.easymile.com
ABOUT KALRAY
Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is a fabless semiconductor company, leading provider in a new generation of processors specialized in Intelligent Data Processing from Cloud to Edge. Kalray MPPA® Intelligent Processors are able to capture and analyze on the fly massive data flows, and interact in real time with the outside world. These processors are capable of running demanding AI algorithms and simultaneously a wide set of different processing and control tasks such as intensive mathematical algorithms, signal processing, network or storage software stacks. Kalray’s Intelligent Processors can be deployed in fast-growing sectors from Cloud to Edge: modern data centers, 5G telecom networks, autonomous vehicles, healthcare equipment, industry 4.0, drones and robots… Kalray’s offering includes processors, acceleration cards and a software suite, for a broad spectrum of customers such as next generation data center equipment manufacturers and service providers, system integrators and consumer product manufacturers such as car makers. Founded in 2008 as a spin-off of CEA French lab, Kalray counts among its investors: Alliance Venture (Renault-Nissan-Mitsubishi), Safran, NXP Semiconductors, CEA and Bpifrance. Read more at: www.kalrayinc.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210106005553/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom